Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ondrey

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 10, 1998
Pallister-Hall syndromeL G Biesecker, F Ondrey
Clinical Biochemistry|February 1, 1992
ETYA, a pleotropic membrane-active arachidonic acid analogue affects multiple signal transduction pathways in cultured transformed mammalian cellsK M Anderson, F Ondrey, J E Harris
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1989
Arachidonic acid analogues: an additional class of membrane--active agents with potential anticancer activityK M Anderson, F Ondrey, J E Harris
Experimental Cell Research|December 1, 1988
Differentiation of U937 cells induced by 5,8,11,14-eicosatetraynoic acid, a competitive inhibitor of arachidonic acid metabolismF Ondrey, K Anderson, D Hoeltgen, et al.
Leukemia Research|February 5, 1999
Do lipoxygenases modulate normal or aberrant lympho-hematopoiesis?K M Anderson, F Ondrey, J E Harris
Cancer Research|March 1, 1989
Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4F Ondrey, J E Harris, K M Anderson
The Prostate|January 1, 1988
Human PC-3 prostate cell line DNA synthesis is suppressed by eicosatetraynoic acid, an in vitro inhibitor of arachidonic acid metabolismK M Anderson, J B Wygodny, F Ondrey, et al.
Anticancer Research|September 1, 1994
The selective 5-lipoxygenase inhibitor A63162 reduces PC3 proliferation and initiates morphologic changes consistent with secretionK M Anderson, T Seed, F Ondrey, et al.
The Annals of Otology, Rhinology, and Laryngology|November 1, 1996
Effect of lipoxygenase inhibition on mucous glycoprotein secretion from chinchilla middle ear epithelial cells in vitroJ Lin, Y Kim, C Less, et al.
Clinical Physiology and Biochemistry|January 1, 1988
Synthesis of eicosanoids by gamma-interferon-differentiated U937 cellsM D Wiederhold, F Ondrey, K M Anderson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 10, 1998
Pallister-Hall syndromeL G Biesecker, F Ondrey
Clinical Biochemistry|February 1, 1992
ETYA, a pleotropic membrane-active arachidonic acid analogue affects multiple signal transduction pathways in cultured transformed mammalian cellsK M Anderson, F Ondrey, J E Harris
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1989
Arachidonic acid analogues: an additional class of membrane--active agents with potential anticancer activityK M Anderson, F Ondrey, J E Harris
Experimental Cell Research|December 1, 1988
Differentiation of U937 cells induced by 5,8,11,14-eicosatetraynoic acid, a competitive inhibitor of arachidonic acid metabolismF Ondrey, K Anderson, D Hoeltgen, et al.
Leukemia Research|February 5, 1999
Do lipoxygenases modulate normal or aberrant lympho-hematopoiesis?K M Anderson, F Ondrey, J E Harris
Cancer Research|March 1, 1989
Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4F Ondrey, J E Harris, K M Anderson
The Prostate|January 1, 1988
Human PC-3 prostate cell line DNA synthesis is suppressed by eicosatetraynoic acid, an in vitro inhibitor of arachidonic acid metabolismK M Anderson, J B Wygodny, F Ondrey, et al.
Anticancer Research|September 1, 1994
The selective 5-lipoxygenase inhibitor A63162 reduces PC3 proliferation and initiates morphologic changes consistent with secretionK M Anderson, T Seed, F Ondrey, et al.
The Annals of Otology, Rhinology, and Laryngology|November 1, 1996
Effect of lipoxygenase inhibition on mucous glycoprotein secretion from chinchilla middle ear epithelial cells in vitroJ Lin, Y Kim, C Less, et al.
Clinical Physiology and Biochemistry|January 1, 1988
Synthesis of eicosanoids by gamma-interferon-differentiated U937 cellsM D Wiederhold, F Ondrey, K M Anderson, et al.
Pageof 2